These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21632843)

  • 1. The molecular basis of von Willebrand disease: the under investigated, the unexpected and the overlooked.
    Hampshire DJ; Goodeve AC
    Haematologica; 2011 Jun; 96(6):798-800. PubMed ID: 21632843
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction of the bleeding time in von Willebrand factor (VWF)-deficient mice using murine VWF.
    Lenting PJ; de Groot PG; De Meyer SF; Vanhoorelbeke K; Pruss C; Lillicrap D; Marx I; Denis CV
    Blood; 2007 Mar; 109(5):2267-8. PubMed ID: 17312004
    [No Abstract]   [Full Text] [Related]  

  • 3. von Willebrand Disease: A Concise Review and Update for the Practicing Physician.
    Swami A; Kaur V
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):900-910. PubMed ID: 27920237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutation.
    Castaman G; Eikenboom JC; Lattuada A; Mannucci PM; Rodeghiero F
    Br J Haematol; 2000 Jan; 108(1):188-90. PubMed ID: 10651743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology.
    Eikenboom JC
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):365-79. PubMed ID: 11686105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility gene card for: von Willebrand disease.
    Cumming AM; Keeney S; Jenkins PV; Nash MJ; O'Donnell JS
    Eur J Hum Genet; 2011 May; 19(5):. PubMed ID: 21206511
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease.
    Federici AB; Canciani MT
    Haematologica; 2009 May; 94(5):610-5. PubMed ID: 19407316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of von Willebrand disease.
    Vink T; Sixma JJ
    Curr Stud Hematol Blood Transfus; 1991; (58):78-83. PubMed ID: 1954779
    [No Abstract]   [Full Text] [Related]  

  • 9. The Y/C1584 mutation of von Willebrand factor in type 2M von Willebrand disease: frequency and clearance of von Willebrand factor.
    Millar CM; Riddel AF; Griffioe A; Jenkin PV; Brown SA
    Br J Haematol; 2005 Aug; 130(3):462-3. PubMed ID: 16042701
    [No Abstract]   [Full Text] [Related]  

  • 10. Biology of inherited coagulopathies: von Willebrand factor.
    Ginsburg D
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1011-20. PubMed ID: 1400069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
    Castaman G; Eikenboom JC; Contri A; Rodeghiero F
    Thromb Haemost; 2000 Aug; 84(2):351-2. PubMed ID: 10959713
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular genetics of von Willebrand disease.
    Ginsburg D; Bowie EJ
    Blood; 1992 May; 79(10):2507-19. PubMed ID: 1586703
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular basis of von Willebrand disease and its clinical implications.
    Haematologica; 2004 Sep; 89(9):1036. PubMed ID: 15377463
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenotypic and genotypic diagnosis of von Willebrand disease: a 2004 update.
    Schneppenheim R; Budde U
    Semin Hematol; 2005 Jan; 42(1):15-28. PubMed ID: 15662612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant von Willebrand factor (VWF) activity in patients with VWF p.Gly1324Ser confirmed in vitro.
    Bowman M; Rimmer E; Houston DS; Israels SJ; James P
    Haemophilia; 2018 Mar; 24(2):e57-e59. PubMed ID: 29341351
    [No Abstract]   [Full Text] [Related]  

  • 16. von Willebrand disease and quantitative variation in von Willebrand factor.
    Mohlke KL; Ginsburg D
    J Lab Clin Med; 1997 Sep; 130(3):252-61. PubMed ID: 9341984
    [No Abstract]   [Full Text] [Related]  

  • 17. Desmopressin-induced thrombocytopenia in von Willebrand disease patients with the Arg611His mutation in the A1 domain of von Willebrand factor.
    Castaman G; Rodeghiero F; Eikenboom J
    Blood; 1996 Apr; 87(7):3061. PubMed ID: 8639930
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of primary haemostasis with a new recombinant von Willebrand factor in patients with von Willebrand disease.
    Trossaërt M; Flaujac C; Jeanpierre E; Drillaud N; Sigaud M; Fouassier M; Ternisien C; de Raucourt E
    Haemophilia; 2020 Mar; 26(2):e44-e48. PubMed ID: 31865618
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
    Rick ME; Krizek DM
    Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acquired von Willebrand syndrome].
    Franchini M
    Recenti Prog Med; 2006; 97(7-8):417-21; quiz 440. PubMed ID: 16913181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.